Over the last 180 days, Rein Therapeutics, Inc. insiders bought a net $74.7K of stock across 10 Form 4 purchases and sales, with 2 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.
Showing the most recent few. Create a free account to see 5 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| REVENUE | $0 | $0 | $0 | $0 |
| OPERATING INCOME | $-50.6M | $-65.1M | $-16.3M | $-27.6M |
| NET INCOME | $-49.9M | $-62.9M | $-15.7M | $-27.3M |
| EPS (DILUTED) | -1.96 | -3.51 | -3.42 | -6.02 |
| OPERATING CASH FLOW | $-19.4M | $-22.3M | $-19.8M | $-24.9M |
| CASH | $3.2M | $12.9M | $17.3M | $5.2M |
No password to create and no card required. We store your email address and nothing else.